Literature DB >> 8069015

Role of MB isoforms (isomers) in the early diagnosis of acute myocardial infarction.

R Baral1, X Luo, H Watanabe, I Yamasawa, C Ibukiyama.   

Abstract

In addition to electrocardiogram (ECG), analysis of creatinine phosphokinase (CPK), lactate dehydrogenase (LDH) and their isoenzymes is commonly employed to diagnose acute myocardial infarction (AMI). The aim of this study was to observe the efficiency of isomers of CPK for early diagnosis of AMI. ECG, though useful in many ways, is not 100% sensitive. The drawback involved with CPK and LDH isoenzymes is the time lag factor in diagnosing AMI early enough for interventional therapy. Recently the subunits of these isoenzymes, namely MM and now the MB isomers are being tested for their effectiveness in the early diagnosis of AMI. In our experience MB isomers were found to be accurate markers in the early diagnosis of AMI. They were especially valuable in diagnosing myocardial infarction not detectable by ECG in cases such as non-Q AMI, cardiomyopathy, and bundle branch block among other such cases.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8069015     DOI: 10.2169/internalmedicine.33.210

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  2 in total

1.  Creatinine Kinase Isoenzyme MB: A Simple Prognostic Marker for Pulmonary Embolism.

Authors:  Mehmet Bozbay; Huseyin Uyarel
Journal:  Lung       Date:  2015-11-07       Impact factor: 2.584

2.  Open-label clinical trial of bezafibrate treatment in patients with fatty acid oxidation disorders in Japan.

Authors:  Kenji Yamada; Hideaki Shiraishi; Eishin Oki; Mika Ishige; Toshiyuki Fukao; Yusuke Hamada; Norio Sakai; Fumihiro Ochi; Asami Watanabe; Sanae Kawakami; Kazuyo Kuzume; Kenji Watanabe; Koji Sameshima; Kiyotaka Nakamagoe; Akira Tamaoka; Naoko Asahina; Saki Yokoshiki; Takashi Miyakoshi; Kota Ono; Koji Oba; Toshiyuki Isoe; Hiroshi Hayashi; Seiji Yamaguchi; Norihiro Sato
Journal:  Mol Genet Metab Rep       Date:  2018-02-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.